HUP0105041A2 - Composition and device for detecting leukocytes in urine - Google Patents

Composition and device for detecting leukocytes in urine

Info

Publication number
HUP0105041A2
HUP0105041A2 HU0105041A HUP0105041A HUP0105041A2 HU P0105041 A2 HUP0105041 A2 HU P0105041A2 HU 0105041 A HU0105041 A HU 0105041A HU P0105041 A HUP0105041 A HU P0105041A HU P0105041 A2 HUP0105041 A2 HU P0105041A2
Authority
HU
Hungary
Prior art keywords
group
optionally substituted
urine
optionally
hydrogen atom
Prior art date
Application number
HU0105041A
Other languages
Hungarian (hu)
Inventor
Nam-Won Huh
Original Assignee
Hypoguard America Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/365,322 external-priority patent/US6348324B1/en
Priority claimed from US09/365,592 external-priority patent/US6528652B1/en
Application filed by Hypoguard America Limited filed Critical Hypoguard America Limited
Publication of HUP0105041A2 publication Critical patent/HUP0105041A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918Carboxylic ester hydrolases (3.1.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A találmány szerinti vegyületek (I), (II) és (III) általánosképletében A jelentése nitrogénatomján védett aminosavmaradék vagynitrogénatomján védett peptidlánc, Rl jelentése adott esetbenszubsztituált heteroarilcsoport, adott esetben szubsztituáltarilcsoporttal szubsztituált alkenilcsoport vagy adott esetbenszubsztituált heteroarilcsoporttal szubsztituált alkenilcsoport, R2jelentése adott esetben szubsztituált fuzionált szénhidrogéngyűrű,amely legalább egy aromás gyűrűt tartalmaz, R3 és R4 jelentéseegymástól függetlenül hidrogénatom, adott esetben szubsztituáltarilcsoport, adott esetben szubsztituált heteroarilcsoport, adottesetben szubsztituált alkilcsoport, adott esetben szubsztituáltalkenilcsoport, adott esetben szubsztituált alkoxicsoport,aminocsoport, adott esetben szubsztituált acilcsoport, halogénatom,nitrocsoport, cianocsoport, -SO3H képletű csoport vagyhidroxilcsoport, azzal a megszorítással, hogy R3 és R4 közül legalábbaz egyik jelentése hidrogénatomtól eltérő. A találmány kiterjed afenti vegyületeket tartalmazó készítményekre és leukociták vizeletbentörténő kimutatására alkalmas eszközre és eljárásra. ÓIn the general formulas (I), (II) and (III) of the compounds according to the invention, A is an amino acid residue protected at its nitrogen atom or a peptide chain protected at its nitrogen atom, Rl is an optionally substituted heteroaryl group, optionally an alkenyl group substituted with a substituted aryl group or an optionally substituted alkenyl group with a substituted heteroaryl group, R2 is an optionally substituted fused hydrocarbon ring, which contains at least one aromatic ring, R3 and R4 are independently a hydrogen atom, optionally substituted aryl group, optionally substituted heteroaryl group, optionally substituted alkyl group, optionally substituted alkenyl group, optionally substituted alkoxy group, amino group, optionally substituted acyl group, halogen atom, nitro group, cyano group, - A group with the formula SO3H or a hydroxyl group, with the restriction that at least one of R3 and R4 has a meaning other than a hydrogen atom. The invention covers preparations containing afentic compounds and a device and method suitable for the detection of leukocytes in urine. HE

HU0105041A 1999-01-21 2000-01-20 Composition and device for detecting leukocytes in urine HUP0105041A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11661399P 1999-01-21 1999-01-21
US14338399P 1999-07-12 1999-07-12
US09/365,322 US6348324B1 (en) 1999-01-21 1999-07-30 Composition and device for detecting leukocytes in urine
US09/365,592 US6528652B1 (en) 1999-01-21 1999-07-30 Composition and device for detecting leukocytes in urine

Publications (1)

Publication Number Publication Date
HUP0105041A2 true HUP0105041A2 (en) 2002-05-29

Family

ID=27494092

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105041A HUP0105041A2 (en) 1999-01-21 2000-01-20 Composition and device for detecting leukocytes in urine

Country Status (6)

Country Link
EP (1) EP1163360A2 (en)
JP (1) JP2002535342A (en)
AU (1) AU2619500A (en)
CA (1) CA2359689A1 (en)
HU (1) HUP0105041A2 (en)
WO (1) WO2000043535A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR980010425A (en) * 1996-07-30 1998-04-30 안홍원 Compositions and measuring instruments for the detection of urine leukocytes and proteolytic enzymes

Also Published As

Publication number Publication date
AU2619500A (en) 2000-08-07
WO2000043535A3 (en) 2000-11-30
JP2002535342A (en) 2002-10-22
WO2000043535A2 (en) 2000-07-27
CA2359689A1 (en) 2000-07-27
EP1163360A2 (en) 2001-12-19

Similar Documents

Publication Publication Date Title
HUP0002483A2 (en) Cetp acticity inhibitors
TR199801594A2 (en) CCR-3 receptor antagonists.
AR010331A1 (en) COMPOUNDS DERIVED FROM 6-PHENYLPYRIDYL-2-AMINE USEFUL AS INHIBITORS US, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND METHODS OF TREATMENT USING THESE COMPOUNDS.
ATE233730T1 (en) ACYLSULFAMOYLBENZOIC ACID AMIDES, CROPPING PROTECTIVE AGENTS CONTAINING THESE AND METHOD FOR THE PRODUCTION THEREOF
HUP0302435A2 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and pharmaceutical compositions containing them
ATE252097T1 (en) N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS
DE60211223D1 (en) Piperidine derivatives as potassium channel blockers
AR050917A1 (en) COMPOUNDS BASED ON 2-AMIDO-TIAZOL THAT PRESENT INHIBITING ACTIVITY OF ENZYMES THAT USE ATP, AND COMPOSITIONS AND USES OF THE SAME
HUP0303849A2 (en) Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors and pharmaceutical compositions containing them
DE69836422D1 (en) N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS
HUP0103096A2 (en) Pharmaceutical composition containing 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
HUP0301514A2 (en) Benzimidazole derivatives, process for their preparation and pharmaceutical compositions containing the same
TR199800011T1 (en) Benzo$g] quinoline t�revleri
HUP0002853A2 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
DK0583485T3 (en) Ethanolamine derivatives with sympathomimetic and anti-pollakisuria effects
HUP0001164A2 (en) Cyclic depsipeptide pf1022 derivatives
BR0100234A (en) Piperidine-4-sulfonamide compounds, process for their preparation and pharmaceutical compositions containing the same
HUP0301176A2 (en) Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof
KR950032077A (en) m-phenylenediamine derivatives and electrophotographic photosensitive members using the same
HUP0000729A2 (en) Novel amide compounds and drugs containing the same
HUP0105041A2 (en) Composition and device for detecting leukocytes in urine
ATE347558T1 (en) CEPHEM COMPOUNDS AND ESBL DETECTION REAGENTS CONTAINING THEM
HUP9701187A1 (en) 2-(1h)-quinolinone derivatives, process for producing them and pharmaceutical compositions containing them
HUP0203603A2 (en) Novel il-8 receptor antagonist indole derivatives and pharmaceutical compositions containing them
HUP0303127A2 (en) Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines